Dr Katie Robb, a researcher focused on improving the earlier diagnosis of cancer and reducing inequalities for cancer patients, has won the prestigious 2018 Scottish Cancer Foundation Prize.

The prize, an honour that recognises excellence in cancer prevention, is awarded with up to £10,000 of funding. Dr Robb plans to use this to accelerate her research to help improve access to cancer screening and reduce the burden of cancer both locally and nationally.

The award was officially made at the Scottish Cancer Conference on Monday 19 November at the Surgeons Hall in Edinburgh.

Dr Robb‘s work focuses on behavioural cancer research encompassing areas such as uptake of cancer screening, understanding cancer risk, and helping people visit their GP if they notice a new or changing symptom. Her work in these areas aims to reduce the number of people dying from cancer by catching cancer at an earlier stage when treatments are more effective.

She is particularly passionate about reducing inequalities in cancer such as uptake of bowel cancer screening, where uptake is almost 25% lower among people living in more deprived areas. Indeed part of her current research focuses on developing and testing an intervention to support people to complete their bowel screening kit at home.

Previously she pioneered work on public perceptions of cancer risk, before going on to co-develop the Cancer Awareness Measure (CAM), which has been widely adopted as the standardised method of assessing cancer awareness across the UK and in other countries. More recently, her work has looked at supporting people with Chronic Obstructive Pulmonary Disease to recognise and seek help promptly for potential lung cancer symptoms.

Dr Robb, who is based at the University’s Institute of Health and Wellbeing, said: “I am delighted to be receiving this award and am very grateful to all the brilliant scientists and clinicians I have collaborated with who have supported this achievement. The prize fund offers an exciting opportunity to accelerate the insights from behavioural science to reduce the burden of cancer locally, nationally and globally.”

Professor Robert Steele, Chairman of the Scottish Cancer Foundation said: ”Raising public awareness of the risk of cancer and improving the uptake of screening services are both essential in helping to detect cancer early and improve survival prospects. Dr Robb’s work has demonstrated success in these important areas and she is a very worthy recipient of this year’s prize.”

Dr Robb was born in Perth and grew up in Bridge of Earn, attending Forgandenny Primary School and Perth High School. She went on to study for an MA in Psychology at the University of St Andrews and an MSc and PhD in Health Psychology at University College London.

The Prize is awarded annually at the Scottish Cancer Conference, and is supported by the Grant Simpson Trust. The award is also accompanied by the Evans Forrest Medal, named in recognition of the founders of the Scottish Cancer Foundation.

  • New PhD Opportunity: Doctoral Training Fellowship in Cancer Prevention

    DEADLINE EXTENDED TO 31ST MAY 2021 The Scottish Cancer Foundation (SCF) focuses on Cancer Prevention, and wishes to promote research, collaborative working across Scotland and public engagement in this area.  Accordingly, the Foundation wishes to invest in the future of Cancer Prevention by providing motivated early-career individuals with research training

  • The Scottish Cancer Foundation Prize & Evans Forrest Medal

    The Scottish Cancer Foundation invites nominations for the 2021 Prize which will be for an individual or organisation that has made an outstanding contribution to the maintenance and/or recovery of cancer services during the COVID-19 pandemic. Applicants may be nominated or self-nominated. The applicant(s) must be living and working in

  • SCPN e-digest – Issue 3 – November 2020

    All articles from the e-digest can be viewed here

  • Scottish Cancer Foundation PhD Opportunity

    We are excited to advertise shortly a new Scottish Cancer Foundation PhD Studentship looking at improving cancer preventive behaviours in cancer patients and their families. Cancer prevention is vital given ever increasing cancer cases and spiralling costs of cancer treatment. The challenge is that supporting people to live a cancer preventive lifestyle (not smoking, being

  • SCPN e-digest Issue 2

    All articles from this issue can be accessed here

  • Skydive Fundraising Success for SCF

    When Elma Nicoll jumped out of a plane thousands of feet over Perthshire, the Scottish Cancer Foundation earned almost £27 for every 100 feet she dropped.   Elma was fulfilling a lifelong ambition to take part in a skydive and, in the process, honoured the memory of her father and

  • The Latest SCF Newsletter is Out Now!

    This issue focuses on this year’s winner of the Scottish Cancer Prevention Prize and Evans Forrest Medal, Dr Christine Campbell. There’s also important information about the aims and activities of Scottish Cancer Foundation, and the success of one of our previous medal winners, Sheila Duffy, Chief Executive of ASH Scotland. 

  • Major honour for Scots researcher

    A Scots researcher whose work on cancer screening has helped to save lives around the world is this year’s winner of the Scottish Cancer Foundation prize which recognises excellence in cancer care and prevention.   Dr Christine Campbell, of the University of Edinburgh’s Usher Institute, has led a series of

  • SCF Lecture: Prostate Cancer- a disease of our time

    On Monday 17th June at 6pm, Scottish Cancer Foundation alongside the Royal Society of Edinburgh hosted a lecture on Prostate cancer delivered by Freddie C. Hamdy FRCSEd, FRCS, FMedSci, Nuffield Professor of Surgery & Urology, University of Oxford. Freddie Hamdy is the Nuffield Professor of Surgery at the University of Oxford, UK,

  • Scottish Cancer Foundation Lecture

    Prostate Cancer: a disease of our time Prostate cancer continues to pose considerable controversies, and to attract interest and attention from the public, the media, scientists and urologists alike. From molecular biology and gigantic leaps in technology, to high-quality randomised controlled trials of screening and treatment, never before has the